Simultaneous Determination of Irbesartan and Hydrochlorothiazide in Tablets by Derivative Spectrophotometry
- 9 January 2003
- journal article
- Published by Taylor & Francis Ltd in Analytical Letters
- Vol. 36 (11), 2485-2495
- https://doi.org/10.1081/al-120024337
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Optimization and validation of a micellar electrokinetic chromatographic method for the analysis of several angiotensin-II-receptor antagonistsJournal of Chromatography A, 2002
- Optimization and validation of a capillary zone electrophoretic method for the analysis of several angiotensin-II-receptor antagonistsJournal of Chromatography A, 2002
- Application of capillary zone electrophoresis to the screening of some angiotensin II receptor antagonistsElectrophoresis, 2002
- Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detectionJournal of Chromatography A, 2001
- Angiotensin II receptor antagonistsThe Lancet, 2000
- Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension.American Journal of Hypertension, 1999
- The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerations.American Journal of Hypertension, 1997
- Clinical overview of irbesartan: a new angiotensin II receptor antagonist.American Journal of Hypertension, 1997
- High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Simple determination of hydrochlorothiazide in human plasma and urine by high performance liquid chromatographyBiomedical Chromatography, 1993